Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 1561 AL 1575

A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease

Kashif M, Sivaprakasam P, Vijendra P, Waseem M, Pandurangan AK.

Curr Pharm Des. 2023;29(43):3428-3441. doi: 10.2174/0113816128264355231121064704.

Radiation Therapy in Alzheimer's Disease: A Systematic Review

Kaul D, Ehret F, Roohani S, Jendrach M, Buthut M, Acker G, Anwar M, Zips D, Heppner F, Prüss H.

Int J Radiat Oncol Biol Phys. 2024 May 1;119(1):23-41. doi: 10.1016/j.ijrobp.2023.11.044. Epub 2023 Nov 30.

Targets, trials and tribulations in Alzheimer therapeutics

Gharat R, Dixit G, Khambete M, Prabhu A.

Eur J Pharmacol. 2024 Jan 5;962:176230. doi: 10.1016/j.ejphar.2023.176230. Epub 2023 Dec 1.

Evidence of Clinical Efficacy and Pharmacological Mechanisms of Resveratrol in the Treatment of Alzheimer's Disease

Jin S, Guan X, Min D.

Curr Alzheimer Res. 2023;20(8):588-602. doi: 10.2174/0115672050272577231120060909.

Evidences and therapeutic advantages of donanemab in the treatment of early Alzheimer's disease

Shukla AK, Misra S.

J Basic Clin Physiol Pharmacol. 2023 Dec 6;35(1-2):25-29. doi: 10.1515/jbcpp-2023-0176. eCollection 2024 Jan 1.

The effect of light therapy on sleep disorders and psychobehavioral symptoms in patients with Alzheimer's disease: A meta-analysis

Zang L, Liu X, Li Y, Liu J, Lu Q, Zhang Y, Meng Q.

PLoS One. 2023 Dec 6;18(12):e0293977. doi: 10.1371/journal.pone.0293977. eCollection 2023.

Understanding Glycogen Synthase Kinase-3: A Novel Avenue for Alzheimer's Disease

Sequeira RC, Godad A.

Mol Neurobiol. 2024 Jul;61(7):4203-4221. doi: 10.1007/s12035-023-03839-1. Epub 2023 Dec 8.

Once upon a time, the Amyloid Cascade Hypothesis

Granzotto A, Sensi SL.

Ageing Res Rev. 2024 Jan;93:102161. doi: 10.1016/j.arr.2023.102161. Epub 2023 Dec 6.

Visualization analysis of exercise intervention on Alzheimer disease based on bibliometrics: Trends, hotspots and topics

Jin Y, Li X, Yuan Q, Huang X, Zhang D.

Medicine (Baltimore). 2023 Dec 8;102(49):e36347. doi: 10.1097/MD.0000000000036347.

Gene therapy: an alternative to treat Alzheimer's disease

Doshi V, Joshi G, Sharma S, Choudhary D.

Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun;397(6):3675-3693. doi: 10.1007/s00210-023-02873-z. Epub 2023 Dec 11.

Effectiveness of epigallocatechin gallate nanoparticles on the in-vivo treatment of Alzheimer's disease in a rat/mouse model: a systematic review

Khalifa MKA, Abdel-Sattar SA, Amin OM, Kohaf NA, Zaky HS, Abd El-Fattah MA, Mohammed KHA, Badawi NM, Mansoor I, Eassa HA.

Daru. 2024 Jun;32(1):319-337. doi: 10.1007/s40199-023-00494-8. Epub 2023 Dec 11.

A light at the end of the tunnel - from mutation identification to a potential treatment for Alzheimer's disease

Lannfelt L.

Ups J Med Sci. 2023 Nov 28;128. doi: 10.48101/ujms.v128.10316. eCollection 2023.

Piecing together the Alzheimer's puzzle: Lecanemab's role in treatment

Ashraf DA, Tariq H, Hassan FS, Kamran F, Khosa WM, Khosa MM.

Neurodegener Dis Manag. 2023 Oct;13(5):257-259. doi: 10.2217/nmt-2023-0026. Epub 2023 Dec 12.

Unravelling the in vitro and in vivo potential of selenium nanoparticles in Alzheimer's disease: A bioanalytical review

Vicente-Zurdo D, Rosales-Conrado N, León-González ME.

Talanta. 2024 Mar 1;269:125519. doi: 10.1016/j.talanta.2023.125519. Epub 2023 Dec 7.

Biomembrane-Derived Nanoparticles in Alzheimer's Disease Therapy: A Comprehensive Review of Synthetic Lipid Nanoparticles and Natural Cell-Derived Vesicles

Gao C, Liu Y, Zhang TL, Luo Y, Gao J, Chu JJ, Gong BF, Chen XH, Yin T, Zhang J, Yin Y.

Int J Nanomedicine. 2023 Dec 7;18:7441-7468. doi: 10.2147/IJN.S436774. eCollection 2023.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias